Sumitomo Mitsui Trust Group
NTLA icon

Sumitomo Mitsui Trust Group’s Intellia Therapeutics NTLA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$25.1M Sell
2,671,265
-154,096
-5% -$1.45M 0.02% 613
2025
Q1
$20.1M Sell
2,825,361
-167,302
-6% -$1.19M 0.01% 638
2024
Q4
$34.9M Sell
2,992,663
-156,736
-5% -$1.83M 0.02% 543
2024
Q3
$64.7M Sell
3,149,399
-108,290
-3% -$2.23M 0.04% 385
2024
Q2
$72.9M Sell
3,257,689
-141,629
-4% -$3.17M 0.05% 344
2024
Q1
$93.5M Sell
3,399,318
-79,244
-2% -$2.18M 0.06% 316
2023
Q4
$106M Sell
3,478,562
-41,733
-1% -$1.27M 0.08% 269
2023
Q3
$111M Buy
3,520,295
+125,639
+4% +$3.97M 0.09% 228
2023
Q2
$138M Buy
3,394,656
+281,692
+9% +$11.5M 0.11% 190
2023
Q1
$116M Buy
3,112,964
+136,962
+5% +$5.1M 0.09% 253
2022
Q4
$104M Buy
2,976,002
+12,074
+0.4% +$421K 0.08% 280
2022
Q3
$166M Buy
2,963,928
+182,792
+7% +$10.2M 0.14% 169
2022
Q2
$144M Sell
2,781,136
-91,133
-3% -$4.72M 0.11% 207
2022
Q1
$209M Buy
2,872,269
+118,366
+4% +$8.6M 0.14% 154
2021
Q4
$326M Buy
2,753,903
+353,970
+15% +$41.9M 0.2% 112
2021
Q3
$322M Sell
2,399,933
-727,670
-23% -$97.6M 0.2% 109
2021
Q2
$506M Sell
3,127,603
-1,679,691
-35% -$272M 0.3% 74
2021
Q1
$386M Sell
4,807,294
-297,068
-6% -$23.8M 0.24% 90
2020
Q4
$278M Sell
5,104,362
-958,154
-16% -$52.1M 0.18% 128
2020
Q3
$121M Sell
6,062,516
-132,673
-2% -$2.64M 0.08% 261
2020
Q2
$130M Sell
6,195,189
-896,074
-13% -$18.8M 0.09% 234
2020
Q1
$86.7M Sell
7,091,263
-87,257
-1% -$1.07M 0.07% 287
2019
Q4
$105M Sell
7,178,520
-61,217
-0.8% -$898K 0.08% 255
2019
Q3
$96.7M Buy
7,239,737
+5,023,077
+227% +$67.1M 0.08% 256
2019
Q2
$36.3M Buy
2,216,660
+1,169,968
+112% +$19.2M 0.03% 533
2019
Q1
$17.9M Buy
+1,046,692
New +$17.9M 0.02% 650